Literature DB >> 33295231

Effects of repeated adolescent exposure to cannabis smoke on cognitive outcomes in adulthood.

Caesar M Hernandez1,2, Caitlin A Orsini3,4,5, Shelby L Blaes3,4, Jennifer L Bizon1,4, Marcelo Febo3,4, Adriaan W Bruijnzeel3,4, Barry Setlow3,4.   

Abstract

BACKGROUND: Cannabis (marijuana) is the most widely used illicit drug in the USA, and consumption among adolescents is rising. Some animal studies show that adolescent exposure to delta 9-tetrahydrocannabinol or synthetic cannabinoid receptor 1 agonists causes alterations in affect and cognition that can persist into adulthood. It is less clear, however, whether similar alterations result from exposure to cannabis via smoke inhalation, which remains the most frequent route of administration in humans. AIMS: To begin to address these questions, a rat model was used to determine how cannabis smoke exposure during adolescence affects behavioral and cognitive outcomes in adulthood.
METHODS: Adolescent male Long-Evans rats were assigned to clean air, placebo smoke, or cannabis smoke groups. Clean air or smoke exposure sessions were conducted daily during adolescence (from P29-P49 days of age ) for a total of 21 days, and behavioral testing began on P70.
RESULTS: Compared to clean air and placebo smoke conditions, cannabis smoke significantly attenuated the normal developmental increase in body weight, but had no effects on several measures of either affect/motivation (open field activity, elevated plus maze, instrumental responding under a progressive ratio schedule of reinforcement) or cognition (set shifting, reversal learning, intertemporal choice). Surprisingly, however, in comparison to clean air controls rats exposed to either cannabis or placebo smoke in adolescence exhibited enhanced performance on a delayed response working memory task.
CONCLUSIONS: These findings are consistent with a growing body of evidence for limited long-term adverse cognitive and affective consequences of adolescent exposure to relatively low levels of cannabinoids.

Entities:  

Keywords:  Cannabis; anxiety; executive function; marijuana; smoke; working memory

Mesh:

Substances:

Year:  2020        PMID: 33295231      PMCID: PMC8187454          DOI: 10.1177/0269881120965931

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.562


  119 in total

1.  Voluntary oral consumption of Δ9-tetrahydrocannabinol by adolescent rats impairs reward-predictive cue behaviors in adulthood.

Authors:  Lauren C Kruse; Jessica K Cao; Katie Viray; Nephi Stella; Jeremy J Clark
Journal:  Neuropsychopharmacology       Date:  2019-04-10       Impact factor: 7.853

2.  Withdrawal following repeated exposure to d-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement.

Authors:  A M Barr; A G Phillips
Journal:  Psychopharmacology (Berl)       Date:  1999-01       Impact factor: 4.530

3.  Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.

Authors:  Joshua A Lile; Thomas H Kelly; Lon R Hays
Journal:  Drug Alcohol Depend       Date:  2011-01-11       Impact factor: 4.492

4.  Marijuana use, diet, body mass index, and cardiovascular risk factors (from the CARDIA study).

Authors:  Nicolas Rodondi; Mark James Pletcher; Kiang Liu; Stephen Benjamin Hulley; Stephen Sidney
Journal:  Am J Cardiol       Date:  2006-06-19       Impact factor: 2.778

5.  Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users.

Authors:  Dayong Lee; Mateus M Bergamaschi; Garry Milman; Allan J Barnes; Regina H C Queiroz; Ryan Vandrey; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2015-10       Impact factor: 3.367

Review 6.  [Cognitive abnormalities and cannabis use].

Authors:  Nadia Solowij; Nicole Pesa
Journal:  Braz J Psychiatry       Date:  2010-05       Impact factor: 2.697

7.  The pharmacology of impulsive behaviour in rats: the effects of drugs on response choice with varying delays of reinforcement.

Authors:  J L Evenden; C N Ryan
Journal:  Psychopharmacology (Berl)       Date:  1996-11       Impact factor: 4.530

8.  Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment.

Authors:  Amir Englund; Paul D Morrison; Judith Nottage; Dominic Hague; Fergus Kane; Stefania Bonaccorso; James M Stone; Avi Reichenberg; Rudolf Brenneisen; David Holt; Amanda Feilding; Lucy Walker; Robin M Murray; Shitij Kapur
Journal:  J Psychopharmacol       Date:  2012-10-05       Impact factor: 4.153

9.  Effects of THC on behavioral measures of impulsivity in humans.

Authors:  Jennifer McDonald; Laura Schleifer; Jerry B Richards; Harriet de Wit
Journal:  Neuropsychopharmacology       Date:  2003-04-30       Impact factor: 7.853

10.  Nabilone produces marked impairments to cognitive function and changes in subjective state in healthy volunteers.

Authors:  K A Wesnes; P Annas; C J Edgar; C Deeprose; R Karlsten; A Philipp; J Kalliomäki; M Segerdahl
Journal:  J Psychopharmacol       Date:  2009-06-12       Impact factor: 4.153

View more
  2 in total

Review 1.  Dos(e)Age: Role of Dose and Age in the Long-Term Effect of Cannabinoids on Cognition.

Authors:  Erica Zamberletti; Tiziana Rubino
Journal:  Molecules       Date:  2022-02-19       Impact factor: 4.411

Review 2.  A Proteomic View of Cellular and Molecular Effects of Cannabis.

Authors:  Morteza Abyadeh; Vivek Gupta; Joao A Paulo; Veer Gupta; Nitin Chitranshi; Angela Godinez; Danit Saks; Mafruha Hasan; Ardeshir Amirkhani; Matthew McKay; Ghasem H Salekdeh; Paul A Haynes; Stuart L Graham; Mehdi Mirzaei
Journal:  Biomolecules       Date:  2021-09-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.